Skip to main content

Table 2 Cancer-related gene expression profiling benchmarks

From: iRDA: a new filter towards predictive, stable, and enriched candidate genes

Dataset Class Samples Genes IR Source
1. Brain GBM/AO 50 (28/22) 12,625 1.27 (Nutt et al., 2003 [54])
2. CNS Survivor/failure 60 (21/39) 7129 1.86 (Pomeroy et al., 2002 [55])
3. Colon Negative/positive 62 (40/22) 2000 1.82 (Alon et al., 1999 [49])
4. Leukemia ALL/AML 72 (47/25) 7129 1.88 (Golub et al., 1999 [56])
5. Lung MPM/ADCA 181 (31/150) 12,533 4.84 (Gordon et al., 2002 [57])
6. Lymphoma DLBCL/FL 77 (58/19) 7129 3.05 (Shipp et al., 2002 [58])
7. Prostate Tumor/normal 102 (52/50) 12,600 1.04 (Singh et al., 2002 [59])